Post by
wallop13 on Aug 21, 2016 5:11pm
FDA & Donnatal
I agree that management did not (and has not) properly disclosed the risk with Donnatal. I also would like to hear from management about what they have submitted to the FDA. I would also like to know why CXR bought this drug knowing it had not completed this process. I used to think management was silent because they had a deal being wrapped up. I'm starting to think they are, and always have been hiding negative issues that were spawned from their greed and incompetence. I could be wrong...... but it's not looking good.
Comment by
Marky1 on Aug 21, 2016 5:16pm
Wallop...Why don't you call IR and ask them....That what Investor Relations do....I m calling tomorrow at 9am sharp..I'm going to ask about the law suits against CXR.....
Comment by
wallop13 on Aug 21, 2016 5:25pm
I can try. IR has not gotten back to me in the past.
Comment by
LaticeInExile on Aug 21, 2016 5:30pm
This post has been removed in accordance with Community Policy
Comment by
Marky1 on Aug 21, 2016 6:27pm
Great post CN....I mildly agree with you....hard getting clear answers out of them! The stock that I owned before was VRX and they were a lot more clear of where the company was heading..
Comment by
Marky1 on Aug 21, 2016 7:17pm
Thank you CN! Have a good evening...